I sure wish I were Aruda, if he's bagged millions already and has a cost basis of 0 with 4 trials reporting results in 6 months, some results as soon as 2 weeks and 6 weeks another trial; after that an interim 6 week data and a final 12 week trial result in July as the finisher of the interim 6 week data. Possibly trial result news on Kevetrin in May/June.

Why did Dr Bertolino (ex Novartis, Pfizer) come on board after the phase 2A results for Prurisol and bring 2 key past coworkers from there with him?

Obviously, they got a good wide view of what ctix has from the management
and the potential for alignment of funds from the big companies as they move trials along. Cellceutix must feel they have some kind of deal, but need the pros who have been in these trenches before to maximize deals.

Aruda doesn't control the outcomes of the trials...